Cell and Gene Therapy Insights Webinars

CELL AND GENE THERAPY INSIGHTS

Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Mindy Miller, Nathan Frank

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Rob Noel, Geddy Hamblen, Christel Fenge

Strategies for streamlined manufacturing and analytics in CGT development

Strategies for streamlined manufacturing and analytics in CGT development

Laura Mueller, Silvio Weber, Dirk Windgassen

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

Fit-for-purpose analytical development for an emerging cell therapy landscape

Fit-for-purpose analytical development for an emerging cell therapy landscape

J Wei, D Rill, F Durst et al

Armor CAR T cells with enhanced potency for cancer immunotherapy

Armor CAR T cells with enhanced potency for cancer immunotherapy

Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

M Dingle, A Carwell, M J. Miller et al

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee

Redefining AAV manufacturing: achieve exceptional performance and quality with an innovative transient cell line

Redefining AAV manufacturing: achieve exceptional performance and quality with an innovative transient cell line

1
2
>
>>

Efficient AAV purification: resin reuse and scalable polish method

Efficient AAV purification: resin reuse and scalable polish method

Nicolas Laroudie, Duncan Dulac

Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success

Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success

Peter Szaraz, Tessel Hammink

Industrialization of AAV manufacturing with Xcite® transient and stable production platforms

Industrialization of AAV manufacturing with Xcite® transient and stable production platforms

Suparna Sanyal, Peng Wang

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel

Next-gen immunotherapy: a guide for CGT developers

Next-gen immunotherapy: a guide for CGT developers

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Fred Parietti, David Shaw, Carl Dargitz

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

Andreja Livk, Sebastijan Peljhan

27 February 2025

Avoiding scale-up pitfalls: upstream process development strategies for AAV manufacturing

Avoiding scale-up pitfalls: upstream process development strategies for AAV manufacturing

Sandy Tseng, Hugh Murray

26 February 2025

Modernizing viral clearance study strategy: regulatory updates and industry best practices

Modernizing viral clearance study strategy: regulatory updates and industry best practices

Audrey Chang, Kathleen Kenney

25 February 2025

1
2
3
4
5
6
7
8
9
10
...
>
>>